Skip to main content
. 2017 Aug 8;8(62):104745–104760. doi: 10.18632/oncotarget.20065

Table 4. Inhibition of compounds on human endothelial cell viability (IC50, μM).

Compound EA.hy926 Compound EA.hy926 Compound EA.hy926
DATU1 3.96 DATU8 102 QDAU5 2.69
DATU2 89.9 DATU9 166 QDAU6 255
DATU3 122 DATU10 90.6 QDAU7 68.5
DATU4 44.8 QDAU1 57.9 QDAU8 76.2
DATU5 246 QDAU2 66.3 QDAU9 13.0
DATU6 24.4 QDAU3 42.6 QDAU10 125
DATU7 96.4 QDAU4 8.64 Sorafenib 16.5